Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
View: Text | PDF
Research Article Aging Immunology

ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI

  • Text
  • PDF
Abstract

The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic proteotoxicity. ROCK1 controls the interplay of HRI with HSP90 and limits the recruitment of HRI and HSP90 to unique p62/SQSTM1 complexes that also contain critical kinases like mTOR complex 1 and TBK1, and proteins involved in RNA metabolism, oxidative damage, and proteostasis like TDP-43. Thus, ROCK1 helps B cells cope with intense pathogen-driven destruction by coordinating the activity of key controllers of B cell differentiation and stress responses. These ROCK1-dependent mechanisms may be widely employed by cells to handle severe environmental stresses, and these findings may be relevant for immune-mediated and age-related neurodegenerative disorders.

Authors

Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis

×

Figure 2

ROCK1 controls humoral responses to Plasmodium infection.

Options: View larger image (or click on image) Download as PowerPoint
ROCK1 controls humoral responses to Plasmodium infection.
WT (black) or ...
WT (black) or CD23-Rock1 (orange) mice were infected with 106 Plasmodium yoelii 17XNL-infected erythrocytes. Uninfected (u) or infected mice at the indicated times pi were analyzed. (A) ROCK1 and ROCK2 activity in purified CD23+ splenic B cells at day 9 pi. Immunoblotting shows p-MYPT1 in IVKs and total ROCK1 and ROCK2 in inputs. Data representative of 3 independent experiments. n.s., nonspecific band; p-, phosphorylated. (B) Parasitemia. Data from at least 5 mice per day and per genotype across 3 independent experiments and show mean ± SEM; P value by nonparametric Mann-Whitney test between the 2 genotypes for each day of infection. (C) Total splenocyte numbers. (D–H) B cell populations by FACS. Frequencies (symbols) and total cell numbers (bars) of splenic B cells (CD19+) (D), GC B cells (B220+GL7+Fas+) (E), atBCs (B220+CD11c+T-bet+) (F), PB/PC (B220int CD138+) (H). (G) Ratio of atBC to GC B cells. Data from at least 5 mice per day and per genotype across 3 independent experiments and show mean ± SEM; P value by unpaired 2-tailed t tests. (I–K) Total IgM, IgG1, and IgG2c levels (I); anti-malaria IgM, IgG1, and IgG2c relative levels (J); and CCL22 and CCL5 levels (K) in the sera by ELISA. Data from at least 5 mice per day and per genotype across 3 independent experiments and show mean ± SEM; P value by 2-way ANOVA followed by Holm-Šídák test for multiple comparisons. (L–O) RNA-Seq of splenic B cell populations sorted from WT or CD23-Rock1 mice at day 9 pi. Data are from 3 independent experiments. (L and M) Top enriched HALLMARK pathways upregulated in CD23-Rock1 compared with WT for activated B cells (L) and PB/PCs (M) at FDR < 0.1. (N and O) GSEA enrichment plots representing selected downregulated pathways in CD23-Rock1 activated B cells (N) and PB/PCs (O). *P value < 0.05, **P value < 0.01, ***P value < 0.001, and ****P value < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts